BEIJING, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the third fiscal quarter ended December 31, 2010 before the U.S. market opens on February 18, 2011. The Company's 2010 fiscal year ends on March 31, 2011.
The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on February 18, 2011 (9:00 p.m. Beijing/Hong Kong time on February 18, 2011).
Conference CallThe dial-in details for the live conference call are as follows:-
U.S. Toll Free Number 1-866-783-2141-
International Dial-in Number 1-857-350-1600Passcode: CMEDCALLA live webcast of the conference call will be available on http://ir.chinameditech.com.
A replay of this webcast will be available for one month on this website.
A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on February 19, 2011. The dial-in details for the replay are as follows:
U.S. Toll Free Number 1-888-286-8010-
International Dial-in Number 1-617-801-6888Passcode: 46276526About China Medical Technologies, Inc.China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs. The Company generates all of its reve